lystn

Andy continues his conversation with Pfizer CEO Albert Bourla, and today they discuss vaccines for kids under 12, when Pfizer expects to receive full FDA approval, vaccinating the rest of the world, and more. Plus, hear Albert's recollection of the day he learned that the Pfizer vaccine trials showed 95.6% efficacy. If you missed Part 1, make sure to go back and listen from the beginning.   Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt. Check out In the Bubble’s Twitter account @inthebubblepod.   Follow Albert Bourla on Twitter @AlbertBourla.    Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.    Support the show by checking out our sponsors!   Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/    Check out these resources from today’s episode:    Read more about federal regulators asking Pfizer and Moderna to expand the size of their vaccine trials in kids ages 5-11: https://www.washingtonpost.com/health/2021/07/26/fda-asks-pfizer-moderna-test-their-vaccines-more-children-under-12-help-rule-out-safety-issues/ Here’s the latest from the FDA on the approval process for COVID-19 vaccines: https://www.cnn.com/2021/07/29/politics/fda-vaccine-full-approval-fast-as-possible/index.html Keep up to date on the global vaccine picture: https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html Find a COVID-19 vaccine site near you: https://www.vaccines.gov/  Order Andy’s book, Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response: https://us.macmillan.com/books/9781250770165    Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.    For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble. See omnystudio.com/listener for privacy information.